Asia-Pacific Cough Syrup Market Forecast 2021-2028

Publisher Name :
Date: 02-Aug-2021
No. of pages: 150

KEY FINDINGS

The Asia-Pacific cough syrup market is set to progress with a CAGR of 3.29% across the forecasting years of 2021 to 2028. The increasing rising rates of air pollution and greenhouse farming, the influence of diverse social, economic, and environmental factors on lung health, and the rising geriatric population are among the top drivers set to facilitate the region's market growth.

MARKET INSIGHTS

The Asia-Pacific cough syrup market growth assessment includes the detailed study of Vietnam, Thailand, India, Indonesia, Australia & New Zealand, South Korea, Japan, China, and the rest of the Asia-Pacific. Chronic cough is highly prevalent in South Korea and affects nearly 3% of Korean adults. Besides, the condition also has a substantial influence on the quality of life. As one of the most rapidly aging nations, South Korea harbored nearly 1.7 million people aged 65 years and over in 2020. Furthermore, the geriatric population, in addition to the surging air pollution, are the main challenges faced, especially from an epidemiological perspective.

On the other hand, air pollution in Indonesia leads to severe diseases such as bronchial asthma, acute respiratory infection, lung cancer, bronchitis, and others. Moreover, problems associated with air pollution have also resulted in approximately 50% of morbidity across the country. Therefore, the abovementioned factors are anticipated to play a vital role in propelling the cough syrup market growth in the Asia-Pacific during the forecast period.

COMPETITIVE INSIGHTS

Leading companies operating in the market are Cipla Limited, The Himalaya Drug Company, Takeda Pharmaceutical Company Limited, Sinopharm Group Co Ltd, etc.

Our report offerings include:

- Explore key findings of the overall market

- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

- Market Segmentation cater to a thorough assessment of key segments with their market estimations

- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Asia-Pacific Cough Syrup Market Forecast 2021-2028

Table Of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Rising Geriatric Population
3.1.2. Increase In Chronic Respiratory Diseases
3.2. Key Restraints
3.2.1. Overdose Risks Associated With Cough Syrup
3.2.2. Government Regulations And Restrictions
4. Key Analytics
4.1. Impact Of Covid-19 On Cough Syrup Market
4.2. Key Market Trends
4.3. Porter's Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
5. Market By Product Type
5.1. Cough Suppressants/Antitussives
5.2. Combination Medications
5.3. Expectorants
6. Market By Age Group
6.1. Adult
6.2. Pediatric
7. Market By Distribution Channels
7.1. Retail Pharmacy
7.2. Hospital Pharmacy
7.3. Online Pharmacy
8. Geographical Analysis
8.1. Asia-Pacific
8.1.1. Market Size & Estimates
8.1.2. Key Drivers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. China
8.1.5.2. Japan
8.1.5.3. India
8.1.5.4. South Korea
8.1.5.5. Indonesia
8.1.5.6. Thailand
8.1.5.7. Vietnam
8.1.5.8. Australia & New Zealand
8.1.5.9. Rest Of Asia-Pacific
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Partnerships & Agreements
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Acella Pharmaceuticals Llc
9.2.3. Astrazeneca Plc
9.2.4. Cipla Limited
9.2.5. Dabur India Ltd
9.2.6. Glaxosmithkline Plc
9.2.7. Glenmark Pharmaceutical Limited
9.2.8. Johnson & Johnson
9.2.9. Merck Kgaa
9.2.10. Novartis International Ag
9.2.11. Pfizer Inc
9.2.12. Proctor & Gamble Co (P&G)
9.2.13. Reckitt Benckiser Group Plc
9.2.14. Sanofi Sa
9.2.15. The Himalaya Drug Company

List Of Tables
Table 1: Market Snapshot - Cough Syrup
Table 2: The Countries With The Largest Percentage Of Total Population Over 65 Years, In 2020
Table 3: Asia-Pacific Cough Syrup Market, By Product Type, Historical Years, 2016-2020 (In $ Million)
Table 4: Asia-Pacific Cough Syrup Market, By Product Type, Forecast Years, 2021-2028 (In $ Million)
Table 5: Asia-Pacific Cough Syrup Market, By Age Group, Historical Years, 2016-2020 (In $ Million)
Table 6: Asia-Pacific Cough Syrup Market, By Age Group, Forecast Years, 2021-2028 (In $ Million)
Table 7: Asia-Pacific Cough Syrup Market, By Distribution Channels, Historical Years, 2016-2020 (In $ Million)
Table 8: Asia-Pacific Cough Syrup Market, By Distribution Channels, Forecast Years, 2021-2028 (In $ Million)
Table 9: Asia-Pacific Cough Syrup Market, By Country, Historical Years, 2016-2020 (In $ Million)
Table 10: Asia-Pacific Cough Syrup Market, By Country, Forecast Years, 2021-2028 (In $ Million)
Table 11: Key Players In Asia-Pacific Cough Syrup Market
Table 12: List Of Mergers & Acquisitions
Table 13: List Of Partnerships & Agreements

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter's Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia-Pacific Cough Syrup Market, Growth Potential, By Product Type, In 2020
Figure 6: Asia-Pacific Cough Syrup Market, By Cough Suppressants/Antitussives, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Cough Syrup Market, By Combination Medications, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Cough Syrup Market, By Expectorants, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Cough Syrup Market, Growth Potential, By Age Group, In 2020
Figure 10: Asia-Pacific Cough Syrup Market, By Adult, 2021-2028 (In $ Million)
Figure 11: Asia-Pacific Cough Syrup Market, By Pediatric, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Cough Syrup Market, Growth Potential, By Distribution Channels, In 2020
Figure 13: Asia-Pacific Cough Syrup Market, By Retail Pharmacy, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Cough Syrup Market, By Hospital Pharmacy, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Cough Syrup Market, By Online Pharmacy, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Cough Syrup Market, Regional Outlook, 2020 & 2028 (In %)
Figure 17: China Cough Syrup Market, 2021-2028 (In $ Million)
Figure 18: Japan Cough Syrup Market, 2021-2028 (In $ Million)
Figure 19: India Cough Syrup Market, 2021-2028 (In $ Million)
Figure 20: South Korea Cough Syrup Market, 2021-2028 (In $ Million)
Figure 21: Indonesia Cough Syrup Market, 2021-2028 (In $ Million)
Figure 22: Thailand Cough Syrup Market, 2021-2028 (In $ Million)
Figure 23: Vietnam Cough Syrup Market, 2021-2028 (In $ Million)
Figure 24: Australia & New Zealand Cough Syrup Market, 2021-2028 (In $ Million)
Figure 25: Rest Of Asia-Pacific Cough Syrup Market, 2021-2028 (In $ Million)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs